Related Experiment Video
Updated: Jul 9, 2026
07:25
Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
Endothelin, sex and hypertension
Rita C Tostes1, Zuleica B Fortes, Glaucia E Callera
1Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, 05508-900 Sao Paulo, Brazil.
Clinical Science (London, England : 1979)
|December 8, 2007
Summary
Endothelins (ETs) influence cardiovascular and renal systems. This review highlights sex differences in ET-1 pathways, crucial for understanding hypertension disparities between males and females.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Hypertension Research
Background:
- Endothelins (ETs), including ET-1, ET-2, and ET-3, are peptides acting via ET(A) and ET(B) receptors.
- ET-1 exhibits vasoconstrictor, mitogenic, pro-inflammatory, and antinatriuretic properties, implicated in cardiovascular diseases and hypertension.
- Hypertension and cardiovascular diseases are more prevalent in men, with males developing more severe hypertension in experimental models.
Purpose of the Study:
- To review sex differences in the endothelin-1 (ET-1) pathway.
- To explore the role of ET-1 in sex-specific hypertension characteristics.
- To investigate the influence of gonadal hormones on ET-1 mediated cardiovascular and renal functions.
Main Methods:
- Literature review focusing on studies examining sex differences in the ET-1 system.
- Analysis of experimental models of hypertension and cardiovascular pathology in males and females.
- Examination of the interplay between gonadal hormones and ET-1 signaling.
Main Results:
- Males exhibit higher ET-1 levels, enhanced ET-1-mediated vasoconstriction, and greater pressor responses compared to females.
- Sex-associated differences in ET(B) receptor number and function are significant in hypertension.
- Gonadal hormones modulate some sex-related differences in the cardiovascular ET pathway.
Conclusions:
- Sex differences in the ET-1 pathway, particularly involving ET(B) receptors, contribute to distinct hypertension characteristics in males and females.
- Understanding these sex-related mechanisms may lead to tailored antihypertensive treatment strategies for men and women.
- Further research is needed to elucidate the precise mechanisms underlying sex differences in the ET-1 peptidergic system.
Related Concept Videos
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...